Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-098414
Filing Date
2025-07-24
Accepted
2025-07-24 17:17:25
Documents
62
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ikna-20250630.htm   iXBRL 10-Q 2403293
2 EX-10.4 ikna-ex10_4.htm EX-10.4 22975
3 EX-31.1 ikna-ex31_1.htm EX-31.1 17705
4 EX-31.2 ikna-ex31_2.htm EX-31.2 17792
5 EX-32.1 ikna-ex32_1.htm EX-32.1 16722
  Complete submission text file 0000950170-25-098414.txt   7923127

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ikna-20250630.xsd EX-101.SCH 1006487
65 EXTRACTED XBRL INSTANCE DOCUMENT ikna-20250630_htm.xml XML 1240924
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40287 | Film No.: 251147896
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)